CN105518143A - 融合蛋白分子和它的使用方法 - Google Patents
融合蛋白分子和它的使用方法 Download PDFInfo
- Publication number
- CN105518143A CN105518143A CN201480016161.8A CN201480016161A CN105518143A CN 105518143 A CN105518143 A CN 105518143A CN 201480016161 A CN201480016161 A CN 201480016161A CN 105518143 A CN105518143 A CN 105518143A
- Authority
- CN
- China
- Prior art keywords
- seqidno
- mutant
- fragment
- aminoacid sequence
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 32
- 108020001507 fusion proteins Proteins 0.000 title description 11
- 102000037865 fusion proteins Human genes 0.000 title description 11
- 230000004927 fusion Effects 0.000 claims abstract description 231
- 102000004127 Cytokines Human genes 0.000 claims abstract description 70
- 108090000695 Cytokines Proteins 0.000 claims abstract description 70
- 239000000203 mixture Substances 0.000 claims abstract description 61
- 230000008685 targeting Effects 0.000 claims abstract description 43
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 18
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 17
- 201000010099 disease Diseases 0.000 claims abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 15
- 230000000694 effects Effects 0.000 claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 13
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 10
- 230000003612 virological effect Effects 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 66
- 239000012634 fragment Substances 0.000 claims description 52
- 108010002350 Interleukin-2 Proteins 0.000 claims description 48
- 102000000588 Interleukin-2 Human genes 0.000 claims description 48
- 108010012048 Kisspeptins Proteins 0.000 claims description 23
- 102000013599 Kisspeptins Human genes 0.000 claims description 23
- -1 Mm.42015 Proteins 0.000 claims description 21
- 102000005962 receptors Human genes 0.000 claims description 19
- 108020003175 receptors Proteins 0.000 claims description 19
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims description 17
- 102100040019 Interferon alpha-1/13 Human genes 0.000 claims description 17
- 102100040247 Tumor necrosis factor Human genes 0.000 claims description 17
- KAHDONZOCXSKII-NJVVDGNHSA-N kisspeptin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C1=CN=CN1 KAHDONZOCXSKII-NJVVDGNHSA-N 0.000 claims description 17
- 108010072844 Endothelin-3 Proteins 0.000 claims description 16
- 102100037850 Interferon gamma Human genes 0.000 claims description 15
- 102100026720 Interferon beta Human genes 0.000 claims description 14
- 108010025020 Nerve Growth Factor Proteins 0.000 claims description 14
- 239000000427 antigen Substances 0.000 claims description 14
- 108091007433 antigens Proteins 0.000 claims description 14
- 102000036639 antigens Human genes 0.000 claims description 14
- 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 claims description 13
- 101000959794 Homo sapiens Interferon alpha-2 Proteins 0.000 claims description 13
- 102100040018 Interferon alpha-2 Human genes 0.000 claims description 13
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 13
- 101001054334 Homo sapiens Interferon beta Proteins 0.000 claims description 12
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 claims description 12
- 230000033228 biological regulation Effects 0.000 claims description 12
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 11
- 102100034845 KiSS-1 receptor Human genes 0.000 claims description 11
- 229920001184 polypeptide Polymers 0.000 claims description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 102000019034 Chemokines Human genes 0.000 claims description 10
- 108010012236 Chemokines Proteins 0.000 claims description 10
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 10
- 102000013275 Somatomedins Human genes 0.000 claims description 10
- 201000011510 cancer Diseases 0.000 claims description 10
- 101000628535 Homo sapiens Metalloreductase STEAP2 Proteins 0.000 claims description 9
- 102100036678 Interleukin-27 subunit alpha Human genes 0.000 claims description 9
- 108010076800 Kisspeptin-1 Receptors Proteins 0.000 claims description 9
- 102100026711 Metalloreductase STEAP2 Human genes 0.000 claims description 9
- 241000315672 SARS coronavirus Species 0.000 claims description 9
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 9
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 9
- 235000018102 proteins Nutrition 0.000 claims description 9
- 102100027203 B-cell antigen receptor complex-associated protein beta chain Human genes 0.000 claims description 8
- 101000654679 Homo sapiens Semaphorin-5B Proteins 0.000 claims description 8
- 101000835745 Homo sapiens Teratocarcinoma-derived growth factor 1 Proteins 0.000 claims description 8
- 108060003951 Immunoglobulin Proteins 0.000 claims description 8
- 102100032780 Semaphorin-5B Human genes 0.000 claims description 8
- 102100026404 Teratocarcinoma-derived growth factor 1 Human genes 0.000 claims description 8
- 102000018358 immunoglobulin Human genes 0.000 claims description 8
- 102000014150 Interferons Human genes 0.000 claims description 7
- 108010050904 Interferons Proteins 0.000 claims description 7
- 102000015336 Nerve Growth Factor Human genes 0.000 claims description 7
- 102000007072 Nerve Growth Factors Human genes 0.000 claims description 7
- 210000004556 brain Anatomy 0.000 claims description 7
- 229940053128 nerve growth factor Drugs 0.000 claims description 7
- 239000003900 neurotrophic factor Substances 0.000 claims description 7
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 6
- 101800004616 Adrenomedullin Proteins 0.000 claims description 6
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 6
- 102100032367 C-C motif chemokine 5 Human genes 0.000 claims description 6
- 102100032937 CD40 ligand Human genes 0.000 claims description 6
- 102000003951 Erythropoietin Human genes 0.000 claims description 6
- 108090000394 Erythropoietin Proteins 0.000 claims description 6
- 102100031511 Fc receptor-like protein 2 Human genes 0.000 claims description 6
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 6
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 6
- 102000004858 Growth differentiation factor-9 Human genes 0.000 claims description 6
- 108090001086 Growth differentiation factor-9 Proteins 0.000 claims description 6
- 101000914491 Homo sapiens B-cell antigen receptor complex-associated protein beta chain Proteins 0.000 claims description 6
- 101000868215 Homo sapiens CD40 ligand Proteins 0.000 claims description 6
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 claims description 6
- 101000764535 Homo sapiens Lymphotoxin-alpha Proteins 0.000 claims description 6
- 101000764294 Homo sapiens Lymphotoxin-beta Proteins 0.000 claims description 6
- 102100039065 Interleukin-1 beta Human genes 0.000 claims description 6
- 108010066979 Interleukin-27 Proteins 0.000 claims description 6
- 102100026238 Lymphotoxin-alpha Human genes 0.000 claims description 6
- 102100026894 Lymphotoxin-beta Human genes 0.000 claims description 6
- 101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 claims description 6
- 108010082093 Placenta Growth Factor Proteins 0.000 claims description 6
- 102100035194 Placenta growth factor Human genes 0.000 claims description 6
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 6
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 6
- 102000036693 Thrombopoietin Human genes 0.000 claims description 6
- 108010041111 Thrombopoietin Proteins 0.000 claims description 6
- 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 claims description 6
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 6
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 6
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 claims description 6
- ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 claims description 6
- 229940105423 erythropoietin Drugs 0.000 claims description 6
- 229940079322 interferon Drugs 0.000 claims description 6
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims description 6
- 210000002845 virion Anatomy 0.000 claims description 6
- 102100024220 CD180 antigen Human genes 0.000 claims description 5
- 102100025221 CD70 antigen Human genes 0.000 claims description 5
- 101000980829 Homo sapiens CD180 antigen Proteins 0.000 claims description 5
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims description 5
- 102000015696 Interleukins Human genes 0.000 claims description 5
- 108010063738 Interleukins Proteins 0.000 claims description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 5
- 102100038437 Sodium-dependent phosphate transport protein 2B Human genes 0.000 claims description 5
- 102400001320 Transforming growth factor alpha Human genes 0.000 claims description 5
- 101800004564 Transforming growth factor alpha Proteins 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 5
- ZGOVYTPSWMLYOF-QEADGSHQSA-N chembl1790180 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CC=3C=CC=CC=3)C(=O)N[C@H](C(=O)N[C@H](CCC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)[C@H](C)O)=O)NC(=O)[C@@H]([C@@H](C)O)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZGOVYTPSWMLYOF-QEADGSHQSA-N 0.000 claims description 5
- 239000003102 growth factor Substances 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 claims description 4
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 4
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 4
- 102100036364 Cadherin-2 Human genes 0.000 claims description 4
- 102100036360 Cadherin-3 Human genes 0.000 claims description 4
- 108010023729 Complement 3d Receptors Proteins 0.000 claims description 4
- 102000011412 Complement 3d Receptors Human genes 0.000 claims description 4
- 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 claims description 4
- 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 claims description 4
- 101000714537 Homo sapiens Cadherin-2 Proteins 0.000 claims description 4
- 101000714553 Homo sapiens Cadherin-3 Proteins 0.000 claims description 4
- 101000846911 Homo sapiens Fc receptor-like protein 2 Proteins 0.000 claims description 4
- 101001034829 Homo sapiens Interferon alpha-10 Proteins 0.000 claims description 4
- 101001034828 Homo sapiens Interferon alpha-14 Proteins 0.000 claims description 4
- 101001034835 Homo sapiens Interferon alpha-16 Proteins 0.000 claims description 4
- 101001034834 Homo sapiens Interferon alpha-17 Proteins 0.000 claims description 4
- 101001034833 Homo sapiens Interferon alpha-21 Proteins 0.000 claims description 4
- 101000959708 Homo sapiens Interferon alpha-4 Proteins 0.000 claims description 4
- 101000959704 Homo sapiens Interferon alpha-5 Proteins 0.000 claims description 4
- 101000959714 Homo sapiens Interferon alpha-6 Proteins 0.000 claims description 4
- 101000961126 Homo sapiens Interferon alpha-7 Proteins 0.000 claims description 4
- 101000999391 Homo sapiens Interferon alpha-8 Proteins 0.000 claims description 4
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims description 4
- 101000834948 Homo sapiens Tomoregulin-2 Proteins 0.000 claims description 4
- 101000844504 Homo sapiens Transient receptor potential cation channel subfamily M member 4 Proteins 0.000 claims description 4
- 101710192051 Interferon alpha-1/13 Proteins 0.000 claims description 4
- 102100039734 Interferon alpha-10 Human genes 0.000 claims description 4
- 102100039733 Interferon alpha-14 Human genes 0.000 claims description 4
- 102100039728 Interferon alpha-16 Human genes 0.000 claims description 4
- 102100039730 Interferon alpha-17 Human genes 0.000 claims description 4
- 102100039729 Interferon alpha-21 Human genes 0.000 claims description 4
- 102100039949 Interferon alpha-4 Human genes 0.000 claims description 4
- 102100039948 Interferon alpha-5 Human genes 0.000 claims description 4
- 102100040007 Interferon alpha-6 Human genes 0.000 claims description 4
- 102100039350 Interferon alpha-7 Human genes 0.000 claims description 4
- 102100036532 Interferon alpha-8 Human genes 0.000 claims description 4
- 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 claims description 4
- 101710112634 Interleukin-13 receptor subunit alpha-2 Proteins 0.000 claims description 4
- 102000052922 Large Neutral Amino Acid-Transporter 1 Human genes 0.000 claims description 4
- 102100023123 Mucin-16 Human genes 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 108091006232 SLC7A5 Proteins 0.000 claims description 4
- 102100026160 Tomoregulin-2 Human genes 0.000 claims description 4
- 101710178300 Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 claims description 4
- 229940112869 bone morphogenetic protein Drugs 0.000 claims description 4
- 230000012010 growth Effects 0.000 claims description 4
- 210000004698 lymphocyte Anatomy 0.000 claims description 4
- 150000003384 small molecules Chemical class 0.000 claims description 4
- 208000030507 AIDS Diseases 0.000 claims description 3
- 102100022987 Angiogenin Human genes 0.000 claims description 3
- 102000003916 Arrestin Human genes 0.000 claims description 3
- 108090000328 Arrestin Proteins 0.000 claims description 3
- 108010028006 B-Cell Activating Factor Proteins 0.000 claims description 3
- 101710129514 B-cell differentiation antigen CD72 Proteins 0.000 claims description 3
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 3
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 3
- 102100023702 C-C motif chemokine 13 Human genes 0.000 claims description 3
- 102100023705 C-C motif chemokine 14 Human genes 0.000 claims description 3
- 102100023703 C-C motif chemokine 15 Human genes 0.000 claims description 3
- 102100023700 C-C motif chemokine 16 Human genes 0.000 claims description 3
- 102100023701 C-C motif chemokine 18 Human genes 0.000 claims description 3
- 102100036842 C-C motif chemokine 19 Human genes 0.000 claims description 3
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims description 3
- 102100036848 C-C motif chemokine 20 Human genes 0.000 claims description 3
- 102100036846 C-C motif chemokine 21 Human genes 0.000 claims description 3
- 102100036850 C-C motif chemokine 23 Human genes 0.000 claims description 3
- 102100036849 C-C motif chemokine 24 Human genes 0.000 claims description 3
- 102100021933 C-C motif chemokine 25 Human genes 0.000 claims description 3
- 102100021935 C-C motif chemokine 26 Human genes 0.000 claims description 3
- 102100021936 C-C motif chemokine 27 Human genes 0.000 claims description 3
- 102100021942 C-C motif chemokine 28 Human genes 0.000 claims description 3
- 102100032366 C-C motif chemokine 7 Human genes 0.000 claims description 3
- 102100034871 C-C motif chemokine 8 Human genes 0.000 claims description 3
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims description 3
- 102100025279 C-X-C motif chemokine 11 Human genes 0.000 claims description 3
- 102100025277 C-X-C motif chemokine 13 Human genes 0.000 claims description 3
- 102100025250 C-X-C motif chemokine 14 Human genes 0.000 claims description 3
- 102100039396 C-X-C motif chemokine 16 Human genes 0.000 claims description 3
- 102100039435 C-X-C motif chemokine 17 Human genes 0.000 claims description 3
- 102100039398 C-X-C motif chemokine 2 Human genes 0.000 claims description 3
- 102100036189 C-X-C motif chemokine 3 Human genes 0.000 claims description 3
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 claims description 3
- 102100036153 C-X-C motif chemokine 6 Human genes 0.000 claims description 3
- 102100036170 C-X-C motif chemokine 9 Human genes 0.000 claims description 3
- 101150049756 CCL6 gene Proteins 0.000 claims description 3
- 101150011672 CCL9 gene Proteins 0.000 claims description 3
- 102000000905 Cadherin Human genes 0.000 claims description 3
- 108050007957 Cadherin Proteins 0.000 claims description 3
- 102100022529 Cadherin-19 Human genes 0.000 claims description 3
- 101150075117 Ccl12 gene Proteins 0.000 claims description 3
- 108091006146 Channels Proteins 0.000 claims description 3
- 108010055166 Chemokine CCL5 Proteins 0.000 claims description 3
- 102100032768 Complement receptor type 2 Human genes 0.000 claims description 3
- 102100035298 Cytokine SCM-1 beta Human genes 0.000 claims description 3
- 102100037354 Ectodysplasin-A Human genes 0.000 claims description 3
- 102000013128 Endothelin B Receptor Human genes 0.000 claims description 3
- 108010090557 Endothelin B Receptor Proteins 0.000 claims description 3
- 102100023688 Eotaxin Human genes 0.000 claims description 3
- 102100031517 Fc receptor-like protein 1 Human genes 0.000 claims description 3
- 101710120224 Fc receptor-like protein 1 Proteins 0.000 claims description 3
- 102100020997 Fractalkine Human genes 0.000 claims description 3
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims description 3
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims description 3
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 3
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 3
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 claims description 3
- 241000700721 Hepatitis B virus Species 0.000 claims description 3
- 102100021866 Hepatocyte growth factor Human genes 0.000 claims description 3
- 102100022623 Hepatocyte growth factor receptor Human genes 0.000 claims description 3
- 102100031000 Hepatoma-derived growth factor Human genes 0.000 claims description 3
- 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 claims description 3
- 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 claims description 3
- 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 claims description 3
- 101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 claims description 3
- 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 claims description 3
- 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 claims description 3
- 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 claims description 3
- 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 claims description 3
- 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 claims description 3
- 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 claims description 3
- 101000897486 Homo sapiens C-C motif chemokine 25 Proteins 0.000 claims description 3
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 claims description 3
- 101000897494 Homo sapiens C-C motif chemokine 27 Proteins 0.000 claims description 3
- 101000897477 Homo sapiens C-C motif chemokine 28 Proteins 0.000 claims description 3
- 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims description 3
- 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 claims description 3
- 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 claims description 3
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims description 3
- 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 claims description 3
- 101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 claims description 3
- 101000858068 Homo sapiens C-X-C motif chemokine 14 Proteins 0.000 claims description 3
- 101000889133 Homo sapiens C-X-C motif chemokine 16 Proteins 0.000 claims description 3
- 101000889048 Homo sapiens C-X-C motif chemokine 17 Proteins 0.000 claims description 3
- 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 claims description 3
- 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 claims description 3
- 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 claims description 3
- 101000947177 Homo sapiens C-X-C motif chemokine 6 Proteins 0.000 claims description 3
- 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 claims description 3
- 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 claims description 3
- 101000804771 Homo sapiens Cytokine SCM-1 beta Proteins 0.000 claims description 3
- 101000978392 Homo sapiens Eotaxin Proteins 0.000 claims description 3
- 101000854520 Homo sapiens Fractalkine Proteins 0.000 claims description 3
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 3
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 claims description 3
- 101001044447 Homo sapiens Interferon kappa Proteins 0.000 claims description 3
- 101001002470 Homo sapiens Interferon lambda-1 Proteins 0.000 claims description 3
- 101001002469 Homo sapiens Interferon lambda-2 Proteins 0.000 claims description 3
- 101001002466 Homo sapiens Interferon lambda-3 Proteins 0.000 claims description 3
- 101000999370 Homo sapiens Interferon omega-1 Proteins 0.000 claims description 3
- 101001002634 Homo sapiens Interleukin-1 alpha Proteins 0.000 claims description 3
- 101001076386 Homo sapiens Interleukin-1 family member 10 Proteins 0.000 claims description 3
- 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 claims description 3
- 101000998146 Homo sapiens Interleukin-17A Proteins 0.000 claims description 3
- 101000998181 Homo sapiens Interleukin-17B Proteins 0.000 claims description 3
- 101000960946 Homo sapiens Interleukin-19 Proteins 0.000 claims description 3
- 101001010591 Homo sapiens Interleukin-20 Proteins 0.000 claims description 3
- 101001010626 Homo sapiens Interleukin-22 Proteins 0.000 claims description 3
- 101000853009 Homo sapiens Interleukin-24 Proteins 0.000 claims description 3
- 101000853002 Homo sapiens Interleukin-25 Proteins 0.000 claims description 3
- 101000853000 Homo sapiens Interleukin-26 Proteins 0.000 claims description 3
- 101000852998 Homo sapiens Interleukin-27 subunit alpha Proteins 0.000 claims description 3
- 101001043821 Homo sapiens Interleukin-31 Proteins 0.000 claims description 3
- 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 claims description 3
- 101000998137 Homo sapiens Interleukin-33 Proteins 0.000 claims description 3
- 101000998132 Homo sapiens Interleukin-34 Proteins 0.000 claims description 3
- 101000998140 Homo sapiens Interleukin-36 alpha Proteins 0.000 claims description 3
- 101000998126 Homo sapiens Interleukin-36 beta Proteins 0.000 claims description 3
- 101001040964 Homo sapiens Interleukin-36 receptor antagonist protein Proteins 0.000 claims description 3
- 101000998122 Homo sapiens Interleukin-37 Proteins 0.000 claims description 3
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 claims description 3
- 101000716729 Homo sapiens Kit ligand Proteins 0.000 claims description 3
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 claims description 3
- 101001128431 Homo sapiens Myeloid-derived growth factor Proteins 0.000 claims description 3
- 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 claims description 3
- 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 claims description 3
- 101000604039 Homo sapiens Sodium-dependent phosphate transport protein 2B Proteins 0.000 claims description 3
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 claims description 3
- 101000830565 Homo sapiens Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 claims description 3
- 101000830603 Homo sapiens Tumor necrosis factor ligand superfamily member 11 Proteins 0.000 claims description 3
- 101000764263 Homo sapiens Tumor necrosis factor ligand superfamily member 4 Proteins 0.000 claims description 3
- 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 claims description 3
- 101000638255 Homo sapiens Tumor necrosis factor ligand superfamily member 8 Proteins 0.000 claims description 3
- 101000638251 Homo sapiens Tumor necrosis factor ligand superfamily member 9 Proteins 0.000 claims description 3
- 108091058536 IL1F9 Proteins 0.000 claims description 3
- 102000026633 IL6 Human genes 0.000 claims description 3
- 102100022469 Interferon kappa Human genes 0.000 claims description 3
- 102100020990 Interferon lambda-1 Human genes 0.000 claims description 3
- 102100020989 Interferon lambda-2 Human genes 0.000 claims description 3
- 102100020992 Interferon lambda-3 Human genes 0.000 claims description 3
- 102100036479 Interferon omega-1 Human genes 0.000 claims description 3
- 102100020881 Interleukin-1 alpha Human genes 0.000 claims description 3
- 102100026015 Interleukin-1 family member 10 Human genes 0.000 claims description 3
- 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 claims description 3
- 102000003814 Interleukin-10 Human genes 0.000 claims description 3
- 108090000174 Interleukin-10 Proteins 0.000 claims description 3
- 102000003815 Interleukin-11 Human genes 0.000 claims description 3
- 108090000177 Interleukin-11 Proteins 0.000 claims description 3
- 108010065805 Interleukin-12 Proteins 0.000 claims description 3
- 102000013462 Interleukin-12 Human genes 0.000 claims description 3
- 108090000176 Interleukin-13 Proteins 0.000 claims description 3
- 102000003816 Interleukin-13 Human genes 0.000 claims description 3
- 108090000172 Interleukin-15 Proteins 0.000 claims description 3
- 102000003812 Interleukin-15 Human genes 0.000 claims description 3
- 101800003050 Interleukin-16 Proteins 0.000 claims description 3
- 102000049772 Interleukin-16 Human genes 0.000 claims description 3
- 102100033461 Interleukin-17A Human genes 0.000 claims description 3
- 102100033101 Interleukin-17B Human genes 0.000 claims description 3
- 102100039879 Interleukin-19 Human genes 0.000 claims description 3
- 102100030692 Interleukin-20 Human genes 0.000 claims description 3
- 102100030704 Interleukin-21 Human genes 0.000 claims description 3
- 102100030703 Interleukin-22 Human genes 0.000 claims description 3
- 108010065637 Interleukin-23 Proteins 0.000 claims description 3
- 102000013264 Interleukin-23 Human genes 0.000 claims description 3
- 102100036671 Interleukin-24 Human genes 0.000 claims description 3
- 102100036680 Interleukin-25 Human genes 0.000 claims description 3
- 102100036679 Interleukin-26 Human genes 0.000 claims description 3
- 102100039064 Interleukin-3 Human genes 0.000 claims description 3
- 102100021596 Interleukin-31 Human genes 0.000 claims description 3
- 102100033501 Interleukin-32 Human genes 0.000 claims description 3
- 102100033500 Interleukin-33 Human genes 0.000 claims description 3
- 102100033499 Interleukin-34 Human genes 0.000 claims description 3
- 102100033474 Interleukin-36 alpha Human genes 0.000 claims description 3
- 102100033498 Interleukin-36 beta Human genes 0.000 claims description 3
- 102100033503 Interleukin-36 gamma Human genes 0.000 claims description 3
- 102100021150 Interleukin-36 receptor antagonist protein Human genes 0.000 claims description 3
- 102100033502 Interleukin-37 Human genes 0.000 claims description 3
- 102000004388 Interleukin-4 Human genes 0.000 claims description 3
- 108090000978 Interleukin-4 Proteins 0.000 claims description 3
- 108010002616 Interleukin-5 Proteins 0.000 claims description 3
- 102100039897 Interleukin-5 Human genes 0.000 claims description 3
- 108090001005 Interleukin-6 Proteins 0.000 claims description 3
- 108010002586 Interleukin-7 Proteins 0.000 claims description 3
- 102100021592 Interleukin-7 Human genes 0.000 claims description 3
- 102000004890 Interleukin-8 Human genes 0.000 claims description 3
- 102100026236 Interleukin-8 Human genes 0.000 claims description 3
- 108090001007 Interleukin-8 Proteins 0.000 claims description 3
- 108010002335 Interleukin-9 Proteins 0.000 claims description 3
- 102000000585 Interleukin-9 Human genes 0.000 claims description 3
- 108090000862 Ion Channels Proteins 0.000 claims description 3
- 102000004310 Ion Channels Human genes 0.000 claims description 3
- 102100020880 Kit ligand Human genes 0.000 claims description 3
- 108090000581 Leukemia inhibitory factor Proteins 0.000 claims description 3
- 101001089108 Lotus tetragonolobus Anti-H(O) lectin Proteins 0.000 claims description 3
- 102100035304 Lymphotactin Human genes 0.000 claims description 3
- 102000004083 Lymphotoxin-alpha Human genes 0.000 claims description 3
- 108090000542 Lymphotoxin-alpha Proteins 0.000 claims description 3
- 101100222387 Mus musculus Cxcl15 gene Proteins 0.000 claims description 3
- 108010056852 Myostatin Proteins 0.000 claims description 3
- 102100040557 Osteopontin Human genes 0.000 claims description 3
- 102100036154 Platelet basic protein Human genes 0.000 claims description 3
- 102100030304 Platelet factor 4 Human genes 0.000 claims description 3
- 101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 claims description 3
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims description 3
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 3
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 3
- 101800001690 Transmembrane protein gp41 Proteins 0.000 claims description 3
- 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 claims description 3
- 102100024568 Tumor necrosis factor ligand superfamily member 11 Human genes 0.000 claims description 3
- 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 claims description 3
- 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 claims description 3
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 claims description 3
- 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 claims description 3
- 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 claims description 3
- 108010072788 angiogenin Proteins 0.000 claims description 3
- 230000010261 cell growth Effects 0.000 claims description 3
- 210000000981 epithelium Anatomy 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 108010052188 hepatoma-derived growth factor Proteins 0.000 claims description 3
- 206010022000 influenza Diseases 0.000 claims description 3
- 108010074108 interleukin-21 Proteins 0.000 claims description 3
- 201000007270 liver cancer Diseases 0.000 claims description 3
- 208000014018 liver neoplasm Diseases 0.000 claims description 3
- 208000018389 neoplasm of cerebral hemisphere Diseases 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 claims description 3
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 3
- 241000712461 unidentified influenza virus Species 0.000 claims description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 3
- 108010013043 Acetylesterase Proteins 0.000 claims description 2
- 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 claims description 2
- 101710166261 B-cell antigen receptor complex-associated protein beta chain Proteins 0.000 claims description 2
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 2
- 108010085074 Brevican Proteins 0.000 claims description 2
- 102100032312 Brevican core protein Human genes 0.000 claims description 2
- 208000011691 Burkitt lymphomas Diseases 0.000 claims description 2
- 102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 claims description 2
- 102000014817 CACNA1A Human genes 0.000 claims description 2
- 102100040835 Claudin-18 Human genes 0.000 claims description 2
- 102100038423 Claudin-3 Human genes 0.000 claims description 2
- 102100038447 Claudin-4 Human genes 0.000 claims description 2
- 102100030886 Complement receptor type 1 Human genes 0.000 claims description 2
- 102100026245 E3 ubiquitin-protein ligase RNF43 Human genes 0.000 claims description 2
- 102100031507 Fc receptor-like protein 5 Human genes 0.000 claims description 2
- 102100037362 Fibronectin Human genes 0.000 claims description 2
- 208000031886 HIV Infections Diseases 0.000 claims description 2
- 102100031546 HLA class II histocompatibility antigen, DO beta chain Human genes 0.000 claims description 2
- 101710154606 Hemagglutinin Proteins 0.000 claims description 2
- 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 claims description 2
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 2
- 101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 claims description 2
- 101000762242 Homo sapiens Cadherin-15 Proteins 0.000 claims description 2
- 101000899410 Homo sapiens Cadherin-19 Proteins 0.000 claims description 2
- 101000749329 Homo sapiens Claudin-18 Proteins 0.000 claims description 2
- 101000882908 Homo sapiens Claudin-3 Proteins 0.000 claims description 2
- 101000882890 Homo sapiens Claudin-4 Proteins 0.000 claims description 2
- 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 claims description 2
- 101000692702 Homo sapiens E3 ubiquitin-protein ligase RNF43 Proteins 0.000 claims description 2
- 101100119857 Homo sapiens FCRL2 gene Proteins 0.000 claims description 2
- 101000846908 Homo sapiens Fc receptor-like protein 5 Proteins 0.000 claims description 2
- 101001027128 Homo sapiens Fibronectin Proteins 0.000 claims description 2
- 101000866281 Homo sapiens HLA class II histocompatibility antigen, DO beta chain Proteins 0.000 claims description 2
- 101001091205 Homo sapiens KiSS-1 receptor Proteins 0.000 claims description 2
- 101000576802 Homo sapiens Mesothelin Proteins 0.000 claims description 2
- 101000721757 Homo sapiens Olfactory receptor 51E2 Proteins 0.000 claims description 2
- 101000982739 Homo sapiens Olfactory receptor 52E1 Proteins 0.000 claims description 2
- 101000982737 Homo sapiens Olfactory receptor 52E2 Proteins 0.000 claims description 2
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 2
- 101000834937 Homo sapiens Tomoregulin-1 Proteins 0.000 claims description 2
- 101000935117 Homo sapiens Voltage-dependent P/Q-type calcium channel subunit alpha-1A Proteins 0.000 claims description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 2
- 241000713340 Human immunodeficiency virus 2 Species 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 108090000543 Ligand-Gated Ion Channels Proteins 0.000 claims description 2
- 102000004086 Ligand-Gated Ion Channels Human genes 0.000 claims description 2
- 206010025323 Lymphomas Diseases 0.000 claims description 2
- 102000003735 Mesothelin Human genes 0.000 claims description 2
- 108090000015 Mesothelin Proteins 0.000 claims description 2
- 102100025096 Mesothelin Human genes 0.000 claims description 2
- 102100025128 Olfactory receptor 51E2 Human genes 0.000 claims description 2
- 102100026988 Olfactory receptor 52E1 Human genes 0.000 claims description 2
- 102100026998 Olfactory receptor 52E2 Human genes 0.000 claims description 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims description 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims description 2
- 102100037603 P2X purinoceptor 5 Human genes 0.000 claims description 2
- 101710189969 P2X purinoceptor 5 Proteins 0.000 claims description 2
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
- 101710176177 Protein A56 Proteins 0.000 claims description 2
- 108010089836 Proto-Oncogene Proteins c-met Proteins 0.000 claims description 2
- 102000000033 Purinergic Receptors Human genes 0.000 claims description 2
- 108010080192 Purinergic Receptors Proteins 0.000 claims description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 2
- 108091006576 SLC34A2 Proteins 0.000 claims description 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 2
- 102000003618 TRPM4 Human genes 0.000 claims description 2
- 108060008245 Thrombospondin Proteins 0.000 claims description 2
- 102000002938 Thrombospondin Human genes 0.000 claims description 2
- 102100026159 Tomoregulin-1 Human genes 0.000 claims description 2
- 102100031228 Transient receptor potential cation channel subfamily M member 4 Human genes 0.000 claims description 2
- 102100025330 Voltage-dependent P/Q-type calcium channel subunit alpha-1A Human genes 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 230000006907 apoptotic process Effects 0.000 claims description 2
- 210000001185 bone marrow Anatomy 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 230000001086 cytosolic effect Effects 0.000 claims description 2
- 230000007123 defense Effects 0.000 claims description 2
- 239000000185 hemagglutinin Substances 0.000 claims description 2
- 208000006454 hepatitis Diseases 0.000 claims description 2
- 231100000283 hepatitis Toxicity 0.000 claims description 2
- 230000036039 immunity Effects 0.000 claims description 2
- 238000010253 intravenous injection Methods 0.000 claims description 2
- 210000005229 liver cell Anatomy 0.000 claims description 2
- 206010025135 lupus erythematosus Diseases 0.000 claims description 2
- 230000000527 lymphocytic effect Effects 0.000 claims description 2
- 230000005012 migration Effects 0.000 claims description 2
- 238000013508 migration Methods 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 210000002307 prostate Anatomy 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 238000010254 subcutaneous injection Methods 0.000 claims description 2
- 239000007929 subcutaneous injection Substances 0.000 claims description 2
- 230000009885 systemic effect Effects 0.000 claims description 2
- 230000009466 transformation Effects 0.000 claims description 2
- 230000001052 transient effect Effects 0.000 claims description 2
- 108010078375 voltage-dependent calcium channel (P-Q type) Proteins 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 27
- 102000018594 Tumour necrosis factor Human genes 0.000 claims 5
- 108050007852 Tumour necrosis factor Proteins 0.000 claims 5
- 102000004379 Adrenomedullin Human genes 0.000 claims 4
- NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 claims 2
- 102100028892 Cardiotrophin-1 Human genes 0.000 claims 2
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 claims 2
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 claims 2
- 102000007055 Endothelin-3 Human genes 0.000 claims 2
- 102100031132 Glucose-6-phosphate isomerase Human genes 0.000 claims 2
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 claims 2
- 101000916283 Homo sapiens Cardiotrophin-1 Proteins 0.000 claims 2
- 102100032352 Leukemia inhibitory factor Human genes 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 108091008875 B cell receptors Proteins 0.000 claims 1
- 102000004506 Blood Proteins Human genes 0.000 claims 1
- 108010017384 Blood Proteins Proteins 0.000 claims 1
- 101710196922 Cadherin-19 Proteins 0.000 claims 1
- 102000006574 Chemokine CXCL13 Human genes 0.000 claims 1
- 108010008955 Chemokine CXCL13 Proteins 0.000 claims 1
- 101710121925 Hemagglutinin glycoprotein Proteins 0.000 claims 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- 101000623899 Mus musculus Mucin-13 Proteins 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 229940096437 Protein S Drugs 0.000 claims 1
- 108700020978 Proto-Oncogene Proteins 0.000 claims 1
- 102000052575 Proto-Oncogene Human genes 0.000 claims 1
- 102000009203 Sema domains Human genes 0.000 claims 1
- 108050000099 Sema domains Proteins 0.000 claims 1
- 101710167605 Spike glycoprotein Proteins 0.000 claims 1
- 101710198474 Spike protein Proteins 0.000 claims 1
- 230000009266 disease activity Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000010255 intramuscular injection Methods 0.000 claims 1
- 239000007927 intramuscular injection Substances 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 210000001501 megacaryocyte Anatomy 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- 208000025113 myeloid leukemia Diseases 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 210000002394 ovarian follicle Anatomy 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 230000002040 relaxant effect Effects 0.000 claims 1
- 230000026683 transduction Effects 0.000 claims 1
- 238000010361 transduction Methods 0.000 claims 1
- 230000005945 translocation Effects 0.000 claims 1
- 239000003446 ligand Substances 0.000 abstract description 17
- 230000009385 viral infection Effects 0.000 abstract description 6
- 239000002245 particle Substances 0.000 abstract description 3
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 description 80
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 54
- 101500026282 Homo sapiens Metastin Proteins 0.000 description 51
- 102400001124 Metastin Human genes 0.000 description 51
- KAHDONZOCXSKII-UHFFFAOYSA-N kisspeptin-54 Chemical compound C1CCC(C(=O)NC(C)C(=O)N2C(CCC2)C(=O)NC(CCC(N)=O)C(=O)NCC(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCC(O)=O)C(=O)NC(CCCCN)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)N2C(CCC2)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C3=CC=CC=C3NC=2)C(=O)NC(CC(N)=O)C(=O)NC(CO)C(=O)NC(CC=2C=CC=CC=2)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC=2C=CC=CC=2)C(N)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(N)=N)NC(=O)C(CO)NC(=O)C(NC(=O)C1N(CCC1)C(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C1N(CCC1)C(=O)C(CCC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CCCNC(N)=N)NC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCC(O)=O)NC(=O)C1N(CCC1)C(=O)C1N(CCC1)C(=O)C1N(CCC1)C(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(NC(=O)CN)C(C)O)CC1=CNC=N1 KAHDONZOCXSKII-UHFFFAOYSA-N 0.000 description 51
- 238000005516 engineering process Methods 0.000 description 50
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 38
- 238000004440 column chromatography Methods 0.000 description 30
- 230000035800 maturation Effects 0.000 description 30
- 241000588724 Escherichia coli Species 0.000 description 28
- 239000004471 Glycine Substances 0.000 description 28
- 210000004962 mammalian cell Anatomy 0.000 description 28
- 102000004190 Enzymes Human genes 0.000 description 27
- 108090000790 Enzymes Proteins 0.000 description 27
- 238000002360 preparation method Methods 0.000 description 27
- 239000000370 acceptor Substances 0.000 description 20
- 235000001014 amino acid Nutrition 0.000 description 18
- 239000013604 expression vector Substances 0.000 description 18
- 241000894006 Bacteria Species 0.000 description 16
- 230000000968 intestinal effect Effects 0.000 description 16
- 238000003146 transient transfection Methods 0.000 description 15
- 102100029109 Endothelin-3 Human genes 0.000 description 14
- 230000009435 amidation Effects 0.000 description 13
- 238000007112 amidation reaction Methods 0.000 description 13
- 210000004899 c-terminal region Anatomy 0.000 description 13
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 13
- 230000001588 bifunctional effect Effects 0.000 description 12
- 230000004048 modification Effects 0.000 description 12
- 238000012986 modification Methods 0.000 description 12
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 11
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 11
- 125000003368 amide group Chemical group 0.000 description 10
- 230000033444 hydroxylation Effects 0.000 description 10
- 238000005805 hydroxylation reaction Methods 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 108010047761 Interferon-alpha Proteins 0.000 description 9
- 102000006992 Interferon-alpha Human genes 0.000 description 9
- 206010027476 Metastases Diseases 0.000 description 9
- 230000009401 metastasis Effects 0.000 description 9
- 229920001192 peptidylglycine Polymers 0.000 description 9
- 210000004881 tumor cell Anatomy 0.000 description 9
- 239000003814 drug Substances 0.000 description 7
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 241000699802 Cricetulus griseus Species 0.000 description 4
- 206010033128 Ovarian cancer Diseases 0.000 description 4
- 206010061535 Ovarian neoplasm Diseases 0.000 description 4
- 108010009583 Transforming Growth Factors Proteins 0.000 description 4
- 102000009618 Transforming Growth Factors Human genes 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- RITKWYDZSSQNJI-INXYWQKQSA-N (2s)-n-[(2s)-1-[[(2s)-4-amino-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-[[(2s)-1-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino] Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 RITKWYDZSSQNJI-INXYWQKQSA-N 0.000 description 3
- 101710186708 Agglutinin Proteins 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 101800004490 Endothelin-1 Proteins 0.000 description 3
- 102400000686 Endothelin-1 Human genes 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 101710146024 Horcolin Proteins 0.000 description 3
- 108010074328 Interferon-gamma Proteins 0.000 description 3
- 101710189395 Lectin Proteins 0.000 description 3
- 101710179758 Mannose-specific lectin Proteins 0.000 description 3
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 3
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 3
- 206010050513 Metastatic renal cell carcinoma Diseases 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000910 agglutinin Substances 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012636 effector Substances 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 108010022560 vasoactive intestinal constrictor Proteins 0.000 description 3
- 102400001318 Adrenomedullin Human genes 0.000 description 2
- 241000370738 Chlorion Species 0.000 description 2
- 108010061994 Coronavirus Spike Glycoprotein Proteins 0.000 description 2
- 102000002045 Endothelin Human genes 0.000 description 2
- 108050009340 Endothelin Proteins 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 101001091223 Homo sapiens Metastasis-suppressor KiSS-1 Proteins 0.000 description 2
- 108090000467 Interferon-beta Proteins 0.000 description 2
- 229910020769 KISS1 Inorganic materials 0.000 description 2
- 101150075823 KISS1 gene Proteins 0.000 description 2
- 102100034841 Metastasis-suppressor KiSS-1 Human genes 0.000 description 2
- 229940059260 amidate Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000002648 combination therapy Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 2
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000009343 monoculture Methods 0.000 description 2
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- SGWFGVQCRDTUQN-UHFFFAOYSA-N (2-prop-2-ynoyloxy-3-prop-2-ynoylsulfanylpropyl) prop-2-ynoate Chemical compound C#CC(=O)OCC(OC(=O)C#C)CSC(=O)C#C SGWFGVQCRDTUQN-UHFFFAOYSA-N 0.000 description 1
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 1
- JYGRAOYMDDFOSM-FQJIPJFPSA-N (4s)-4-[[(2s)-4-carboxy-2-[[(2s)-3-carboxy-2-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]propanoyl]amino]butanoyl]amino]-5-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentano Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN JYGRAOYMDDFOSM-FQJIPJFPSA-N 0.000 description 1
- JIGIJNKESDREHJ-WOUDKVOTSA-N 374675-18-0 Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)CC1=CC=C(O)C=C1 JIGIJNKESDREHJ-WOUDKVOTSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 102100027207 CD27 antigen Human genes 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000030168 Endothelin A Receptor Human genes 0.000 description 1
- 108010090549 Endothelin A Receptor Proteins 0.000 description 1
- 108010087819 Fc receptors Proteins 0.000 description 1
- 102000009109 Fc receptors Human genes 0.000 description 1
- 108010014612 Follistatin Proteins 0.000 description 1
- 102000016970 Follistatin Human genes 0.000 description 1
- 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 241000709715 Hepatovirus Species 0.000 description 1
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
- 101000880080 Homo sapiens Ectodysplasin-A Proteins 0.000 description 1
- 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 description 1
- 101000972946 Homo sapiens Hepatocyte growth factor receptor Proteins 0.000 description 1
- 101001033279 Homo sapiens Interleukin-3 Proteins 0.000 description 1
- 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 description 1
- 101000883798 Homo sapiens Probable ATP-dependent RNA helicase DDX53 Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 108091058560 IL8 Proteins 0.000 description 1
- 102400001121 Kisspeptin-10 Human genes 0.000 description 1
- 101800001692 Kisspeptin-10 Proteins 0.000 description 1
- 102400001122 Kisspeptin-13 Human genes 0.000 description 1
- 101800005274 Kisspeptin-13 Proteins 0.000 description 1
- 102400001123 Kisspeptin-14 Human genes 0.000 description 1
- 101800005275 Kisspeptin-14 Proteins 0.000 description 1
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102100026712 Metalloreductase STEAP1 Human genes 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 101100042271 Mus musculus Sema3b gene Proteins 0.000 description 1
- 108050000637 N-cadherin Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010092528 Phosphate Transport Proteins Proteins 0.000 description 1
- 102000016462 Phosphate Transport Proteins Human genes 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 102100038236 Probable ATP-dependent RNA helicase DDX53 Human genes 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 108010018777 Prostatein Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000006265 Renal cell carcinoma Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108091006207 SLC-Transporter Proteins 0.000 description 1
- 102000037054 SLC-Transporter Human genes 0.000 description 1
- 240000002825 Solanum vestissimum Species 0.000 description 1
- 235000018259 Solanum vestissimum Nutrition 0.000 description 1
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 description 1
- 102000007000 Tenascin Human genes 0.000 description 1
- 108010008125 Tenascin Proteins 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 108700025316 aldesleukin Proteins 0.000 description 1
- 229960005310 aldesleukin Drugs 0.000 description 1
- 230000002001 anti-metastasis Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000003305 autocrine Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
- 102000003675 cytokine receptors Human genes 0.000 description 1
- 108010057085 cytokine receptors Proteins 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 108010053500 delicious peptide Proteins 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 1
- 239000007999 glycylglycine buffer Substances 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 229960001388 interferon-beta Drugs 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 229940100630 metacresol Drugs 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000000064 prostate epithelial cell Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960004964 temozolomide Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 208000001608 teratocarcinoma Diseases 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
蛋白 | IL2(aldesleukin) | IL2-Kisspeptin-54 | Kisspeptin-54 |
EC50(pM) | 31.24+1.463 | 32.73+1.942 | N/A* |
Claims (43)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361802169P | 2013-03-15 | 2013-03-15 | |
US61/802169 | 2013-03-15 | ||
PCT/CN2014/073459 WO2014139468A1 (en) | 2013-03-15 | 2014-03-14 | Fusion protein molecules and method of use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105518143A true CN105518143A (zh) | 2016-04-20 |
CN105518143B CN105518143B (zh) | 2020-02-21 |
Family
ID=51535876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480016161.8A Active CN105518143B (zh) | 2013-03-15 | 2014-03-14 | 融合蛋白分子和它的使用方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN105518143B (zh) |
WO (1) | WO2014139468A1 (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017190684A1 (zh) * | 2016-05-06 | 2017-11-09 | 王牧林 | 白细胞介素组合及其用途 |
WO2018028157A1 (zh) * | 2016-08-10 | 2018-02-15 | 中山大学 | 一种vc-car分子及在清除hiv-1感染细胞中的应用 |
CN109504660A (zh) * | 2018-11-02 | 2019-03-22 | 温州启星生物技术有限公司 | 一种第四代car-t细胞及其构建方法和应用 |
CN110101843A (zh) * | 2018-02-01 | 2019-08-09 | 北京科诺科服生物科技有限公司 | 一种抗肿瘤蛋白质及其应用 |
WO2020024922A1 (zh) * | 2018-07-30 | 2020-02-06 | 张晋宇 | 蛋白质异二聚体及其用途 |
CN111440244A (zh) * | 2020-04-09 | 2020-07-24 | 诺未科技(北京)有限公司 | 靶向vegfr2的转移性癌疫苗 |
CN112957472A (zh) * | 2021-02-05 | 2021-06-15 | 无锡市第五人民医院 | 靶向ccl19/ccr7的乙型肝炎免疫治疗剂及其用途 |
CN113018442A (zh) * | 2021-03-19 | 2021-06-25 | 武汉大学 | 细胞因子il1f5在制备检测、预防和治疗肿瘤的产品中的应用 |
CN114106207A (zh) * | 2022-01-24 | 2022-03-01 | 诺未科技(北京)有限公司 | Ccl5的用途 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9815871B2 (en) | 2013-04-23 | 2017-11-14 | President And Fellows Of Harvard College | Genetic reprogramming of bacterial biofilms |
JP6916524B2 (ja) | 2015-04-06 | 2021-08-11 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 機能的タンパク質配列をディスプレイする生合成アミロイドに基づく材料 |
CN106065033A (zh) * | 2016-03-17 | 2016-11-02 | 中国药科大学 | 一种细胞因子融合抗体的制备及其应用 |
US11098133B2 (en) | 2016-05-19 | 2021-08-24 | President And Fellows Of Harvard College | Methods of making gels and films using curli nanofibers |
CA3031955A1 (en) * | 2016-07-29 | 2018-02-01 | Juno Therapeutics, Inc. | Immunomodulatory polypeptides and related compositions and methods |
EP3594242A4 (en) * | 2017-04-05 | 2020-12-09 | Korea Research Institute of Bioscience and Biotechnology | NK CELL-ACTIVATING FUSION PROTEIN, NK CELL AND PHARMACEUTICAL COMPOSITION THEREOF |
JOP20200020B1 (ar) | 2017-08-03 | 2023-09-17 | Amgen Inc | ميوتينات إنترليوكين-21 وطرق العلاج |
CR20210319A (es) | 2018-01-12 | 2021-07-27 | Amgen Inc | ANTICUERPOS ANTI-PD-1 Y MÉTODOS DE TRATAMIENTO (Div. 2020-330) |
SG11202011349PA (en) * | 2018-05-14 | 2020-12-30 | Werewolf Therapeutics Inc | Activatable interleukin-2 polypeptides and methods of use thereof |
EP3923975A4 (en) * | 2019-02-13 | 2023-04-19 | University of Florida Research Foundation, Inc. | TARGETING A LUNG-RESIDENT TNFR2+ CDC2 (R2D2) SUBPOPULATION TO TREAT ASTHMA |
US20230043257A1 (en) * | 2020-01-21 | 2023-02-09 | Jinyu Zhang | Pharmaceutical composition and use thereof |
CN113789346A (zh) * | 2021-08-25 | 2021-12-14 | 北京伟德杰生物科技有限公司 | 长效化重组人白细胞介素2融合蛋白及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102083451A (zh) * | 2008-06-12 | 2011-06-01 | 赛恩泰新公司 | 癌症的抑制 |
WO2011146902A1 (en) * | 2010-05-21 | 2011-11-24 | Merrimack Pharmaceuticals, Inc. | Bi-specific fusion proteins |
US8076288B2 (en) * | 2004-02-11 | 2011-12-13 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides having glucose lowering activity |
-
2014
- 2014-03-14 WO PCT/CN2014/073459 patent/WO2014139468A1/en active Application Filing
- 2014-03-14 CN CN201480016161.8A patent/CN105518143B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8076288B2 (en) * | 2004-02-11 | 2011-12-13 | Amylin Pharmaceuticals, Inc. | Hybrid polypeptides having glucose lowering activity |
CN102083451A (zh) * | 2008-06-12 | 2011-06-01 | 赛恩泰新公司 | 癌症的抑制 |
WO2011146902A1 (en) * | 2010-05-21 | 2011-11-24 | Merrimack Pharmaceuticals, Inc. | Bi-specific fusion proteins |
Non-Patent Citations (7)
Title |
---|
JEONG-HYUNG LEE ET AL.: "KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene", 《JOURNAL OF THE NATIONAL CANCER INSTITUTE》 * |
PDB:1M47_A: "Chain A, Interleukin-2", 《GENBANK》 * |
ROLAND E. KOTERMANN: "Antibody-cytokine fusion proteins", 《ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS》 * |
汪世龙 等: "《蛋白质化学》", 31 August 2012 * |
熊娟: "肿瘤坏死因子超家族成员分子结构的研究进展", 《医学综述》 * |
牛天贵 等: "《食品免疫学》", 30 September 2010, 中国农业大学出版社 * |
王建六 等: "《肿瘤免疫研究进展》", 31 July 1997, 河南医科大学出版社 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017190684A1 (zh) * | 2016-05-06 | 2017-11-09 | 王牧林 | 白细胞介素组合及其用途 |
WO2018028157A1 (zh) * | 2016-08-10 | 2018-02-15 | 中山大学 | 一种vc-car分子及在清除hiv-1感染细胞中的应用 |
US10633432B2 (en) | 2016-08-10 | 2020-04-28 | Shenzhen City Of Regeneration Biological Pharmaceutical Technology Co., Ltd. | VC-CAR molecule and use thereof in removing HIV-1 infected cells |
CN110101843A (zh) * | 2018-02-01 | 2019-08-09 | 北京科诺科服生物科技有限公司 | 一种抗肿瘤蛋白质及其应用 |
WO2020024922A1 (zh) * | 2018-07-30 | 2020-02-06 | 张晋宇 | 蛋白质异二聚体及其用途 |
CN112513276A (zh) * | 2018-07-30 | 2021-03-16 | 张晋宇 | 蛋白质异二聚体及其用途 |
CN112513276B (zh) * | 2018-07-30 | 2024-03-15 | 张晋宇 | 蛋白质异二聚体及其用途 |
US11795203B2 (en) | 2018-07-30 | 2023-10-24 | Jinyu Zhang | Protein heterodimer and use thereof |
CN109504660B (zh) * | 2018-11-02 | 2021-08-06 | 温州启星生物技术有限公司 | 一种第四代car-t细胞及其构建方法和应用 |
CN109504660A (zh) * | 2018-11-02 | 2019-03-22 | 温州启星生物技术有限公司 | 一种第四代car-t细胞及其构建方法和应用 |
CN111440244A (zh) * | 2020-04-09 | 2020-07-24 | 诺未科技(北京)有限公司 | 靶向vegfr2的转移性癌疫苗 |
CN112957472A (zh) * | 2021-02-05 | 2021-06-15 | 无锡市第五人民医院 | 靶向ccl19/ccr7的乙型肝炎免疫治疗剂及其用途 |
CN113018442A (zh) * | 2021-03-19 | 2021-06-25 | 武汉大学 | 细胞因子il1f5在制备检测、预防和治疗肿瘤的产品中的应用 |
CN114106207A (zh) * | 2022-01-24 | 2022-03-01 | 诺未科技(北京)有限公司 | Ccl5的用途 |
Also Published As
Publication number | Publication date |
---|---|
WO2014139468A1 (en) | 2014-09-18 |
CN105518143B (zh) | 2020-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105518143A (zh) | 融合蛋白分子和它的使用方法 | |
Saxton et al. | Emerging principles of cytokine pharmacology and therapeutics | |
US7582288B2 (en) | Methods of targeting multiple cytokines | |
AU702184B2 (en) | Immunoconjugates II | |
EP0785276A1 (en) | Modification of peptide and protein | |
JPH07223968A (ja) | 免疫抱合体 | |
KR20220128968A (ko) | 사이토카인 기반 면역세포 및 그의 면역 치료 용도 | |
US6242570B1 (en) | Production and use of recombinant protein multimers with increased biological activity | |
Zhang et al. | Development and biological activity of long-acting recombinant human interferon-α2b | |
NOBUHARA et al. | The inhibition of neoplastic cell proliferation with human natural tumor necrosis factor | |
KR20230157760A (ko) | 인터루킨21 변이체, 이를 포함하는 융합단백질 및 이의 용도 | |
Qin et al. | Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice | |
Zdravkovic et al. | Physiology and pathology of cytokine: Commercial production and medical use | |
Uzé et al. | High efficiency targeting of IFN-α activity: Possible applications in fighting tumours and infections | |
KR102171360B1 (ko) | 사이토카인 융합 폴리펩티드, 및 이를 포함하는 사이토카인 라이브러리 | |
Ghosh et al. | Physiological proteins in therapeutics: A current review on interferons | |
EP1731531B1 (en) | Multiple cytokine-antibody complexes | |
Ryff et al. | Interferons and interleukins | |
Zhao et al. | Albumin fusion of interleukin-28B: production and characterization of its biological activities and protein stability | |
Liu et al. | Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells | |
Williams et al. | Cytokine modulated cell-membrane bound tumour necrosis factor expression is associated with enhanced monocyte-mediated killing of human leukaemic targets | |
Ryff et al. | Interferons and interleukins | |
Chen et al. | Signaling molecules in the microenvironment of hepatocellular carcinoma | |
Kamada et al. | Generating functional mutant proteins to create highly bioactive anticancer biopharmaceuticals | |
List et al. | Primary Antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240322 Address after: 277722 Shenda Technology Entrepreneurship Park, Shenshan Town, Lanling County, Linyi City, Shandong Province Patentee after: SHANDONG KAISEN PHARMA Co.,Ltd. Country or region after: China Address before: Room 1501, 3rd Floor, No. 88 Science and Technology Innovation 6th Street, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 101111 Patentee before: BEIJING PHARMASCIENCES Co.,Ltd. Country or region before: China |